Physician profile
Fred O Butler
NPI 1174592166
$1,552.95
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $991 · 2020: $502 · 2021: $38.33 · 2023: $21.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $239.55 | 2019-2020 | |
| Genentech USA, INC. | $185.17 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $154.95 | 2020 | |
| Genzyme Corporation | $105.63 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $100.45 | 2019-2020 | |
| Janssen Biotech, INC. | $100.01 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $79.58 | 2019-2020 | |
| Pfizer INC. | $69.97 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $64.91 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $59.96 | 2019-2023 | Imbruvica |
| Merck Sharp & Dohme LLC | $46.18 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.52 | 2019 | |
| Celgene Corporation | $40.21 | 2019 | |
| Incyte Corporation | $34.99 | 2019-2020 | |
| Eisai INC. | $33.23 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $30.63 | 2020 | |
| Exelixis INC. | $24.83 | 2019-2020 | |
| Tesaro, INC. | $22.28 | 2019 | |
| Gilead Sciences, INC. | $19.60 | 2019 | |
| Seagen INC. | $16.61 | 2020 | |
| Daiichi Sankyo INC. | $16.08 | 2020 | |
| Rigel Pharmaceuticals, INC. | $15.80 | 2019 | |
| Emd Serono, INC. | $14.98 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.71 | 2019 | |
| Karyopharm Therapeutics INC. | $11.85 | 2020 | |
| Clovis Oncology, INC. | $11.27 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.